Ligand validation:6OP4

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OP4_IMD_D_602	92%	73%	0.071	0.961	0.5	0.56	-	-	1	0	100%	1
6OP4_IMD_B_603	76%	82%	0.108	0.945	0.3	0.49	-	-	0	0	100%	1
6OP4_IMD_B_602	76%	79%	0.11	0.945	0.16	0.68	-	-	0	0	100%	1
6OP4_IMD_D_601	75%	85%	0.096	0.928	0.39	0.35	-	-	0	0	100%	1
6OP4_IMD_C_503	62%	73%	0.139	0.93	0.27	0.75	-	-	1	0	100%	1
6OP4_IMD_A_503	51%	71%	0.177	0.932	0.36	0.74	-	-	0	0	100%	1
6OP4_IMD_B_605	44%	86%	0.151	0.879	0.23	0.48	-	-	0	0	100%	1
6OP4_IMD_A_504	22%	72%	0.234	0.847	0.59	0.48	-	-	2	0	100%	1
6OP4_IMD_D_603	11%	81%	0.241	0.759	0.22	0.59	-	-	0	0	100%	1
7JRF_IMD_A_503	97%	78%	0.062	0.974	0.23	0.65	-	-	0	0	100%	1
4TKV_IMD_B_602	95%	73%	0.071	0.975	0.21	0.81	-	-	0	0	100%	1
4TKU_IMD_B_603	94%	72%	0.077	0.978	0.31	0.77	-	-	0	0	100%	1
5BVH_IMD_B_602	93%	72%	0.058	0.953	0.18	0.88	-	-	0	0	100%	1
6OP3_IMD_B_602	89%	54%	0.085	0.964	0.53	1.24	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.